Page 314 - HIVMED_v21_i1.indb
P. 314

Page 8 of 8  Original Research


                 believe that self-reported episodes of serious sickness   Data availability statement
                 within a month are less likely to vary significantly from   Due to the private nature of the data, data for the study will be
                 the actual episodes.
              •  Adherence to ART use in this study was not assessed, but   available only upon request and approval of  Authorising
                 rather assumed, based on satisfactory HIV viral load   Ministry of Health.
                 measurements of participants. There is a possibility that
                 the observed health experiences measured in this study   Disclaimer
                 might not have been sorely because of inability to   The views and opinions expressed in this article are those of
                 purchase NCD medication alone, but because of
                 interaction  with non-compliance to NCD prescribed   the authors and do not necessarily reflect the official policy or
                 medication  or use of traditional  medication for NCDs   position of any affiliated agency of the authors.
                 that was common among cases in this study.
              •  Survival  was  not  assessed  in  this  study  to  compare   References
                 survival rates between cases and controls. Whilst the   1.  Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS
                 6-month follow-up was adequate to assess trends in health   report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010.
                 expenses and health experiences, it was not long enough   2.  Harris  TG,  Rabkin  M,  El-Sadr  WM.  Achieving  the  fourth  90:  Healthy  aging  for
                 for survival analysis to be performed. Survival analysis   people  living  with  HIV.  AIDS.  2018;32(12):1563.  https://doi.org/10.1097/QAD.
                                                                      0000000000001870
                 would have required longer a follow-up period of 5–15   3.  Narayan  KV,  Miotti  PG,  Anand  NP,  et  al.  HIV  and  noncommunicable  disease
                 years, which would not have been feasible for this study.  comorbidities in the era of antiretroviral therapy: A vital agenda for research in
              •  Representativeness of our research data to other African   low-and  middle-income  country  settings.  AIDS.  2014;67:S2–S7.  https://doi.
                                                                      org/10.1097/QAI.0000000000000267
                 countries with stable economies might be limited, in part,   4.  Negin J, Mills EJ, Bärnighausen T. Aging with HIV in Africa: The challenges of living
                 because of the economic crisis faced by Zimbabwe, which   longer. AIDS. 2012;26(01):S1. https://doi.org/10.1097/QAD.0b013e3283560f54
                 makes it unique in sub-Saharan Africa.             5.  Nugent R, Barnabas RV, Golovaty I, et al. Costs and cost-effectiveness of HIV/NCD
                                                                      integration in Africa: From theory to practice. AIDS. 2018;32(Suppl 1):S83. https://
                                                                      doi.org/10.1097/QAD.0000000000001884
              Conclusion                                            6.  Shade SB, Osmand T, Luo A, et al. Cost of integrating non-communicable disease
                                                                      (NCD) care into Ugandan HIV/medical clinics in the SEARCH study. 9th International
              HIV-NCD comorbidity causes an additional burden to PLWH   AIDS Society (IAS) Conference 23–26 July 2017; Paris, France: IAS. 2017
              because of increased transport costs, NCD prescribed   7.  WHO.  Working  group  on  the  inclusion  of  NCDs  in  other  programmatic  areas:
                                                                      World Health Organization global coordination mechanism on the prevention and
              medication expenses and more productive days lost because   control of noncommunicable diseases. Working group 3.1 (2016-2017). Geneva:
              of illness.  Access to antihypertensives and diabetic   World Health Organization; 2018.
              medications is influenced by interplay of the key determinants   8.  Haregu  TN,  Oldenburg  B,  Sestwe  G,  Elliott  J,  Nanayakkara  V.  Epidemiology  of
                                                                      comorbidity of HIV/AIDS and non-communicable diseases in developing countries:
              of health, which include income, gender, age and geographical   A systematic review. J Glob Health Care Syst. 2012;2(1):1–2.
              location. The success of HIV programmes does not only rely   9.  Zimbabwe. The National Health Strategy for Zimbabwe, 2009-2013: Equity and
              on improving access to the diagnosis and treatment of HIV.   quality in health: A people’s right. Harare: Ministry of Health & Child Welfare;
                                                                      2009.
              Addressing the complications of HIV-related NCDs and the   10. WHO. Closing the gap in a generation: Health equity through action on the social
              long-term costs of ART and its occasional potential for harm   determinants of health: WHO commission on social determinants of health final
                                                                      report. Geneva: World Health Organization; 2008.
              will be essential if health outcomes in Zimbabweans living   11. Türmen  T.  Gender  and  HIV/AIDS.  Int  J  Gynaecol  Obstet.  2003;82(3):411–418.
              with HIV are to be optimised.                           https://doi.org/10.1016/S0020-7292(03)00202-9
                                                                    12. Peacock D, Stemple L, Sawires S, Coates TJ. Men, HIV/AIDS, and human rights.
              Acknowledgements                                        J  Acquir  Immune  Defic  Syndr.  2009;51(Suppl  3):S119–S125.  https://doi.org/
                                                                      10.1097/QAI.0b013e3181aafd8a
              The authors acknowledge the support received from the   13. Camlin CS, Ssemmondo E, Chamie G, et al. Men ‘missing’ from population-based
                                                                      HIV  testing:  Insights  from  qualitative  research.  AIDS  Care.  2016;28(Suppl  3):
              University of KwaZulu-Natal in conducting the study.    67–73. https://doi.org/10.1080/09540121.2016.1164806
                                                                    14. Dworkin  SL.  Who  is  epidemiologically  fathomable  in  the  HIV/AIDS  epidemic?.
                                                                      Gender,  sexuality,  and  intersectionality  in  public  health.  Cult  Health  Sex.
              Competing interests                                     2005;7(6):615–623. https://doi.org/10.1080/13691050500100385
                                                                    15. Guariguata L, de Beer I, Hough R, et al. Diabetes, HIV and other health determinants
              The authors have declared that no competing interest exists.  associated  with  absenteeism  among  formal  sector  workers  in  Namibia.  BMC
                                                                      Public Health. 2012;12(1):44. https://doi.org/10.1186/1471-2458-12-44
                                                                    16. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs
              Authors’ contributions                                  among older adults  with  diabetes. Diabetes Care. 2004;27(2):384–391.https://
                                                                      doi.org/10.2337/diacare.27.2.384
              All authors contributed equally to this work.         17. Maciel  RA,  Klück  HM,  Durand  M,  Sprinz  E.  Comorbidity  is  more  common  and
                                                                      occurs earlier in persons living with HIV than in HIV-uninfected matched controls,
                                                                      aged 50 years and older: A cross-sectional study. Int J Infect Dis. 2018;70:30–35.
              Funding information                                     https://doi.org/10.1016/j.ijid.2018.02.009
                                                                    18. Peltzer  K,  Pengpid  S.  Utilization  and  practice  of  traditional/complementary/
              The study was funded by University of KwaZulu-Natal,    alternative medicine (T/CAM) in Southeast Asian nations (ASEAN) member states.
              under PhD research grants.                              Stud Ethno-Med. 2015;9(2):209–218. https://doi.org/10.1080/09735070.2015.1
                                                                      1905437







                                           http://www.sajhivmed.org.za 306  Open Access
   309   310   311   312   313   314   315   316   317   318   319